PRACTICAL ONCOLOGY JOURNAL ›› 2013, Vol. 27 ›› Issue (4): 363-366.doi: 10.3969/j.issn.1002-3070.2013.04.015

• Review • Previous Articles     Next Articles

Recent progress on Wnt pathway and osteosarcoma

WEI Tianli, QU Guofan   

  1. Department of Orthopedics, The Affiliated Tumor Hospital of Harbin Medical University, Harbin 150081, China
  • Received:2013-01-09 Online:2013-08-28 Published:2013-08-13

Abstract: Osteosarcoma is the most prevalent primary malignant bone tumor in children and teenagers with a poor survival in 40% of the victims.The Wnt/β-catenin signaling pathway has been shown to play a major role in bone cell differentiation, proliferation and apoptosis.It is a critical component of bone mass regulation and required for bone to respond to mechanical loading.The pathway is tightly regulated by a number of modulator proteins.Mutations in pathway components that result in aberrant regulation are involved in a number of bone diseases, especially Osteosarcoma.The use of Wnt pathway associated markers appear promising for osteosarcoma.Drugs targeting the Wnt pathway will gain even more attention.

CLC Number: